Insider Trading History of Leonard John M

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Leonard John M since 2013. This trader's CIK number is 1563584. At the time of last reporting, Leonard John M was the President and CEO of Intellia Therapeutics, Inc.. (stock ticker symbol NTLA). Also see all insider trading activities at Intellia Therapeutics, Inc..

Note that in the past LEONARD JOHN M also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Intellia Therapeutics, Inc. (NTLA) by Leonard John M

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 NTLA 0 $0 26,807 $326,509 0 $0
2024 NTLA 0 $0 19,223 $566,309 0 $0
2023 NTLA 0 $0 0 $0 15,696 $0
2022 NTLA 0 $0 2,493 $279,851 7,848 $0
2021 NTLA 0 $0 444,371 $46,304,219 696,324 $10,117,270
2020 NTLA 0 $0 180,000 $5,673,245 180,000 $1,720,750
2018 NTLA 0 $0 8,400 $201,600 0 $0

Yearly summary of insider trading at Abbvie Inc. (ABBV) by Leonard John M

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 ABBV 0 $0 74,649 $2,844,820 76,350 $2,157,169

Yearly summary of insider trading at Chimerix Inc (CMRX) by Leonard John M

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 CMRX 0 $0 5,000 $25,165 0 $0
2015 CMRX 1,000 $47,380 0 $0 0 $0
2014 CMRX 4,000 $116,000 0 $0 0 $0

Yearly summary of insider trading at Iqvia Holdings Inc. (IQV) by Leonard John M

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 IQV 0 $0 20,200 $3,090,600 20,200 $1,308,354


Insider trading activities at 4 companies by Leonard John M:

1. Intellia Therapeutics, Inc. (NTLA)

2. Abbvie Inc. (ABBV)

3. Chimerix Inc (CMRX)

4. Iqvia Holdings Inc. (IQV)

Table 1. Insider trading of Intellia Therapeutics, Inc. (NTLA) by Leonard John M

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-01-03 NTLA Sale 26,807 12.18 326,509
2024-01-03 NTLA Sale 19,223 29.46 566,309
2023-01-01 NTLA Option Ex 7,848 .00 0
2023-01-01 NTLA Option Ex 7,848 .00 0
2022-01-01 NTLA Option Ex 7,848 .00 0
2022-01-01 NTLA Sale 2,493 112.25 279,851
2021-08-31 NTLA Sale 37,833 155.00 5,864,115
2021-08-30 NTLA Sale 38,804 156.86 6,086,679
2021-09-01 NTLA Sale 44,735 170.00 7,604,950
2021-08-31 NTLA Option Ex 37,833 14.58 551,605
2021-08-30 NTLA Option Ex 38,804 13.99 542,867
2021-09-01 NTLA Option Ex 44,735 20.88 934,066
2021-08-23 NTLA Option Ex 27,139 13.40 363,662
2021-08-23 NTLA Sale 27,139 152.71 4,144,478
2021-08-19 NTLA Option Ex 22,682 13.40 303,938
2021-08-19 NTLA Sale 22,682 151.44 3,434,962
2021-04-13 NTLA Option Ex 25,937 10.36 268,577
2021-04-01 NTLA Option Ex 71,041 13.99 993,863
2021-04-01 NTLA Sale 38,209 83.50 3,190,451
2021-02-09 NTLA Sale 28,043 75.00 2,103,225
2021-02-09 NTLA Option Ex 56,718 6.83 387,383
2021-02-05 NTLA Sale 22,942 67.94 1,558,679
2021-02-05 NTLA Option Ex 40,000 13.40 536,000
2021-02-03 NTLA Sale 67,856 72.50 4,919,560
2021-02-01 NTLA Option Ex 200,000 15.45 3,089,600
2021-02-01 NTLA Sale 109,889 64.14 7,048,610
2021-02-03 NTLA Option Ex 117,060 18.33 2,145,709
2020-12-31 NTLA Option Ex 14,375 .00 0
2021-01-05 NTLA Sale 6,239 55.86 348,510
2020-11-27 NTLA Option Ex 35,000 16.44 575,400
2020-11-27 NTLA Sale 35,000 38.50 1,347,500
2020-11-25 NTLA Option Ex 50,000 6.83 341,500
2020-11-25 NTLA Sale 50,000 36.00 1,800,000
2020-11-16 NTLA Option Ex 20,000 14.58 291,600
2020-11-16 NTLA Sale 20,000 34.00 680,000
2020-11-04 NTLA Sale 50,000 26.00 1,300,000
2020-11-04 NTLA Option Ex 50,000 6.83 341,500
2020-10-07 NTLA Option Ex 5,000 6.83 34,150
2020-10-07 NTLA Sale 5,000 21.83 109,149
2020-09-01 NTLA Sale 5,000 21.83 109,149
2020-09-01 NTLA Option Ex 5,000 6.83 34,150
2020-08-06 NTLA Sale 5,000 21.83 109,149
2020-08-06 NTLA Option Ex 5,000 6.83 34,150
2020-07-01 NTLA Option Ex 5,000 6.83 34,150
2020-07-01 NTLA Sale 5,000 21.83 109,149
2020-06-03 NTLA Option Ex 5,000 6.83 34,150
2020-06-03 NTLA Sale 5,000 21.83 109,149
2018-05-14 NTLA Sale 8,400 24.00 201,600

Table 2. Insider trading of Abbvie Inc. (ABBV) by Leonard John M

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-03-15 ABBV Option Ex 46,700 28.86 1,347,902
2013-03-15 ABBV Sale 46,700 38.45 1,795,615
2013-03-08 ABBV Sale 27,949 37.54 1,049,205
2013-02-19 ABBV Option Ex 29,650 27.29 809,267

Table 3. Insider trading of Chimerix Inc (CMRX) by Leonard John M

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-09-15 CMRX Sale 5,000 5.03 25,165
2015-08-21 CMRX Buy 1,000 47.38 47,380
2014-11-05 CMRX Buy 4,000 29.00 116,000

Table 4. Insider trading of Iqvia Holdings Inc. (IQV) by Leonard John M

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-12-20 IQV Option Ex 20,200 64.77 1,308,354
2019-12-20 IQV Sale 20,200 153.00 3,090,600

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Leonard John M (President and CEO of Intellia Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.